Pharmacoeconomic analysis of the use of first- and second-line drugs in the treatment of multiple sclerosis

Pharmacoeconomic analysis of the use of first- and second-line drugs in the treatment of multiple sclerosis

Objective: to make a pharmacoeconomic comparison of the administration of first- and second-line drugs in the treatment of multiple sclerosis through cost, cost-effectiveness, and budget impact analyses using the 2015 state prices.Material and methods. A pharmacoeconomic analysis was carried out on...

Full description

Bibliographic Details
Main Authors: V. R. Mkrtchyan, L. V. Brylev, O. V. Davydova, A. V. Belyanin, I. A. Shpak, A. M. Sergeev
Format: Article
Language:Russian
Published: IMA-PRESS LLC 2015-10-01
Series:Неврология, нейропсихиатрия, психосоматика
Subjects:
multiple sclerosis
pharmacoeconomics
interferon-β1a
interferon-β1b
glatiramer acetate
natalizumab
fingolimod
Online Access:https://nnp.ima-press.net/nnp/article/view/528

Internet

https://nnp.ima-press.net/nnp/article/view/528

Similar Items